ACT
The investment seeks long-term capital appreciation.\n The fund is an actively-managed exchange-traded fund that invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from tobacco and alcoholic beverages and companies that derive at least 50% of their net revenue from the marijuana and hemp industry or have at least 50% of their company assets dedicated to lawful research and development of cannabis or cannabinoid-related products. It will invest primarily in U.S. exchange listed equity securities, including common and preferred stock and ADRs.
Enact Holdings, Inc. (ACT) is rated C (2.3/5) on Deltasharpe Prism, scored against Financial Services sector peers. Its strongest pillar is Profitability (B+); its weakest is Revisions (F). The rating has held at C for 5 weeks.
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-17 | B (3.2) | D+ (1.7) | B+ (3.7) | C+ (2.8) | F (0.0) | C (2.3) |
| 2026-11-10 | B (3.2) | D+ (1.8) | B+ (3.7) | B- (3.0) | F (0.0) | C (2.3) |
| 2026-11-03 | B (3.2) | D+ (1.8) | B+ (3.7) | B (3.2) | F (0.0) | C (2.4) |
| 2026-10-27 | B (3.2) | D+ (1.8) | B+ (3.7) | B (3.2) | F (0.0) | C (2.4) |
| 2026-10-20 | B (3.2) | D+ (1.8) | B+ (3.7) | B (3.5) | F (0.0) | C (2.4) |